Research In Brief
This article was originally published in The Gray Sheet
Executive Summary
Hip replacement trends
You may also be interested in...
FDA Announces Possible Link Between Breast Implants And Cancer
In response to data suggesting that breast implants may be associated with a rare form of cancer, FDA plans to work with manufacturers on revised product labeling, the agency announced Jan. 26.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.